Pilot Study for the Validity of a Content-based Information Provision Tool Aimed at Improving the Hospitalization Experience of Liver Transplant Patients
Launched by SAMSUNG MEDICAL CENTER · May 16, 2024
Trial Information
Current as of February 12, 2025
Not yet recruiting
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • \[Patients\]
- • Adults aged 18 and over
- • Patients who are scheduled to undergo or have undergone liver transplant surgery
- • Recruited through a call for research participants and have consented to participate in this study
- • \[Medical Staff\]
- • Adults aged 18 and over
- • Medical staff at Samsung Medical Center involved in the post-liver transplant treatment process
- Exclusion Criteria:
- • \[Patients\]
- • Individuals who have not consented to participate in this study
- • Individuals whose health condition makes it difficult to participate in the intervention
- • During the research period, the researcher will check if the brochure content has been shared during surveys or interviews with the research participants (information dissemination). If information dissemination is confirmed, the participant will be excluded from the study.
- • \[Medical Staff\]
- • Individuals who have not consented to participate in this study
- • Medical staff not involved in the liver transplant treatment process
About Samsung Medical Center
Samsung Medical Center (SMC) is a leading healthcare institution in South Korea, renowned for its commitment to advancing medical research and innovation. As a prominent clinical trial sponsor, SMC integrates cutting-edge technology and expert clinical practices to conduct rigorous studies aimed at improving patient outcomes. The center is dedicated to fostering collaborations with global research entities and adhering to the highest ethical standards, ensuring the integrity and reliability of its clinical trials. With a focus on diverse therapeutic areas, SMC plays a pivotal role in translating scientific discoveries into effective treatments, ultimately enhancing the quality of healthcare worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0